Wednesday, May 18, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

CUBA PRESENTS AT

Havana, Apr 30 (Prensa Latina) The file containing the protocol to carry out the phase III clinical trial with the neuroprotective drug NeuroEPO in patients with ataxia, was presented for approval to the Cuban regulatory entity, they disclosed on Friday.